Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme
Section snippets
Materials
7-EFC and 7-hydroxy-4-trifluoromethylcoumarin (7-HFC) were purchased from Molecular Probes Inc. (Eugene, OR). NADPH was from Sigma Chemical Co. (St. Louis, MO). [4-14C]-testosterone was obtained from Amersham Biosciences (Piscataway, NJ). Authentic steroid standards were obtained from Steraloids Inc. (Newport, RI). Oligonucleotide primers were obtained from Sigma Genosys (Woodlands, TX). The QuikChange site-directed mutagenesis kit was obtained from Stratagene (La Jolla, CA). The GeneClean kit
Inhibition studies with 4-CPI and BIF
To examine the effect of the mutations on inhibitor binding, P450 2B4dH/H226Y and site-directed mutants were analyzed for 4-CPI and BIF inhibition using 7-EFC O-deethylation. The results are presented in Table 2 and Fig. 1. Because of the dominance of the strong coordinate bond between the heme iron of P450 and nitrogen of the imidazole ring, phenylimidazole compounds show non-competitive inhibition, such that the IC50 value is comparable to the Ki value. Furthermore, inhibition studies with
Conclusions
This is the first study to examine the utility of the ligand-bound P450 2B4dH/H226Y X-ray crystal structures for predicting differential inhibition by BIF and 4-CPI as well as substrate turnover and stereo- and regioselectivity. The study was carried out by substituting amino acid residues that interact with 4-CPI-, BIF-, or both with smaller and/or larger ones followed by characterization of enzyme inhibition and catalysis. Interestingly, T302A, I363A, V367A, and V477A, which were created
Acknowledgments
The authors thank Ms. Ling Sun for her technical assistance. We also thank Drs. Harshica Fernando, B.K. Muralidhara, and YongHong Zhao for their expert suggestions. Financial support was provided by NIH Grant ES03619 and Center Grant ES06676 (to J.R.H.).
References (28)
J. Biol. Chem.
(1992)- et al.
Mol. Cell
(2000) J. Inorg. Biochem.
(2002)- et al.
J. Biol. Chem.
(2003) - et al.
Arch. Biochem. Biophys.
(2004) - et al.
Arch. Biochem. Biophys.
(2005) - et al.
J. Biol. Chem.
(2004) - et al.
J. Biol. Chem.
(2006) - et al.
J. Biol. Chem.
(2006) - et al.
J. Biol. Chem.
(1997)
Arch. Biochem. Biophys.
Biochem. Biophys. Res. Commun.
Arch. Biochem. Biophys.
J. Biol. Chem.
Cited by (19)
Beyond active site residues: overall structural dynamics control catalysis in flavin-containing and heme-containing monooxygenases
2019, Current Opinion in Structural BiologyCitation Excerpt :As catalysis involves subtle, concerted conformational changes spanning a large part of the enzyme, allosteric effects are frequently observed and sometimes drastic. In CYP2Bs, mutations of residues remote from the active site caused not only a switch in selectivity for some substrates, but also profound functional changes affecting the enzyme’s catalytic rates and inhibition [45]. Interestingly, mutations targeting active site residues produced much smaller changes [46].
X-ray crystal structure of the cytochrome P450 2B4 active site mutant F297A in complex with clopidogrel: Insights into compensatory rearrangements of the binding pocket
2013, Archives of Biochemistry and BiophysicsCitation Excerpt :The spectral dissociation constant (Ks) were obtained by fitting the data to the equation for “tight binding” 2ΔA = 2ΔA=(ΔAmax/[E0])−[KD + [I0] + [E0] + (KD + [I0] + [E0])2−(4[E0][I0])1/2] for high affinity ligand using SpectraLab software [31]. IC50 values were determined as described previously [32] using 7-EFC O-deethylation measured in a final reaction volume of 100 μl at clopidogrel concentrations of 0.1–5 μM with a substrate concentration of 50 μM. The activities were plotted against inhibitor concentration in SigmaPlot (Systat Software, Inc., Point Richmond, CA).
Rational engineering of cytochromes P450 2B6 and 2B11 for enhanced stability: Insights into structural importance of residue 334
2010, Archives of Biochemistry and BiophysicsCitation Excerpt :To surmount these difficulties, a variety of approaches have been used including removal of the membrane associated N-terminal domain, directed evolution, and site-directed mutagenesis [7–10]. Furthermore, rational engineering and directed evolution have been used to locate important non-active site amino acids and alter function of P450s in the 2B subfamily [7,10–13]. Measures of protein stability used to examine 2B enzymes include thermal and pressure tolerance [7,14–16].
Identification and analysis of conserved sequence motifs in cytochrome P450 family 2: Functional and structural role of a motif<sup>187</sup> RFDYKD <sup>192</sup> in CYP2B enzymes
2008, Journal of Biological ChemistryCitation Excerpt :Each kinetic experiment included H226Y, K186A, and the CSM 8 mutants simultaneously for more accurate comparison of the data. Inhibition Studies—Enzyme inhibition was measured using the 7-EFC O-deethylation assay in a final reaction volume of 100 μl at 0.005-0.1 μm 4-CPI and 0.1-2.5 μm BIF concentrations as described previously (31). BIF and 4-CPI inhibition studies for all the mutants utilized 0.025 μm P450.
Thermodynamic Fidelity of the Mammalian Cytochrome P450 2B4 Active Site in Binding Substrates and Inhibitors
2008, Journal of Molecular BiologyRe-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide
2007, Archives of Biochemistry and Biophysics